Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDowning Strate. Regulatory News (DSM)

  • This share is currently suspended. It was suspended at a price of 4.05
  • There is currently no data for DSM

Statement re Requisitioned General Meeting

25 Jul 2024 07:00

RNS Number : 7226X
Downing Strategic Micro-Cap IT PLC
25 July 2024
 

Downing Strategic Micro-Cap Investment Trust plc (the "Company")

LEI Number: 213800QMYPUW4POFFX69

Board Receives Support From Independent Advisors

 

 

Following the receipt of a request to requisition a general meeting of the Company (the "Requisition") from Vidacos Nominees Limited, acting as nominee of Milkwood Capital Limited ("Milkwood"), the resolutions put forward at the General Meeting on 5 August 2024 have been assessed by a key leading independent proxy advisory agency working in the financial markets.

The assessment of this globally respected advisor is to vote Against each of the Requisitioned Resolutions, which is in line with the board's unanimous recommendation.

As stated before the Board considers that Milkwood's decision to lodge the Requisition is wholly self-interested and disruptive when the Board and the Investment Manager are focused on returning cash to shareholders pursuant to the shareholder approved managed wind-down of the Company. 

Shareholders are reminded, if voting by proxy, that the latest time and date for lodging proxy forms or submitting proxy instructions online in connection with the requisitioned general meeting is 10.00 a.m. on 1 August 2024, however, intermediaries will have set earlier deadlines for underlying holders to provide them with voting instructions. The record date and time for the purposes of being entitled to vote at the requisitioned general meeting is 6.00 p.m. on 1 August 2024, and the meeting will be held on 5 August 2024 at 10.00 a.m.

Hugh Aldous, chairman of the Company, commented: "It is clear that the leading governance advisors, who are trusted by major fund managers around the world, are in agreement that the proposals would put the Company under the leadership of directors who are not independent and will not necessarily represent the interests of all shareholders. I am pleased that they agree with the Board in rejecting these self-interested proposals."

If you are in any doubt about what action to take in respect of matters in connection with your investment in DSM (including whether to vote or not, or how to vote) you should consult your independent professional adviser authorised pursuant to the Financial Services and Markets Act 2000"

 

For further information, please contact:

Chairman

Hugh Aldous

Tel: 020 7416 7780

 

Dickson Minto Advisers LLP

Douglas Armstrong

Tel: 020 7649 6823

 

Media Contacts - Garfield Advisory

Andrew Garfield

Tel: 07974 982337

Jason Nisse

Tel: 07769 688618

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSEAFMLELSEFW
Date   Source Headline
20th May 202412:43 pmRNSNet Asset Value(s)
20th May 202411:42 amRNSTransaction in Own Shares
20th May 202410:20 amRNSHolding(s) in Company
17th May 202411:11 amRNSNet Asset Value(s)
16th May 202411:14 amRNSNet Asset Value(s)
15th May 202412:50 pmRNSNet Asset Value(s)
15th May 202410:12 amRNSDirectorate Change
14th May 202411:41 amRNSNet Asset Value(s)
13th May 202412:24 pmRNSNet Asset Value(s)
10th May 202412:28 pmRNSNet Asset Value(s)
9th May 202412:31 pmRNSNet Asset Value(s)
8th May 202410:17 amRNSNet Asset Value(s)
7th May 20241:34 pmRNSNet Asset Value(s)
3rd May 20246:01 pmRNSTransaction in Own Shares
3rd May 202412:51 pmRNSNet Asset Value(s)
2nd May 20249:51 amRNSNet Asset Value(s)
1st May 202411:07 amRNSNet Asset Value(s)
1st May 20249:36 amRNSTotal Voting Rights
30th Apr 202411:50 amRNSNet Asset Value(s)
29th Apr 202411:45 amRNSNet Asset Value(s)
29th Apr 202410:31 amRNSTransaction in Own Shares
26th Apr 202411:22 amRNSNet Asset Value(s)
25th Apr 202410:44 amRNSNet Asset Value(s)
24th Apr 202410:40 amRNSNet Asset Value(s)
23rd Apr 202411:43 amRNSNet Asset Value(s)
22nd Apr 20243:40 pmRNSNet Asset Value(s)
22nd Apr 202412:38 pmRNSTransaction in Own Shares
19th Apr 202411:29 amRNSNet Asset Value(s)
18th Apr 202410:59 amRNSNet Asset Value(s)
17th Apr 202411:43 amRNSNet Asset Value(s)
16th Apr 202412:41 pmRNSNet Asset Value(s)
15th Apr 202412:56 pmRNSNet Asset Value(s)
12th Apr 202411:46 amRNSNet Asset Value(s)
11th Apr 202411:00 amRNSNet Asset Value(s)
10th Apr 202412:00 pmRNSNet Asset Value(s)
9th Apr 202410:55 amRNSNet Asset Value(s)
8th Apr 202411:30 amRNSNet Asset Value(s)
5th Apr 202411:27 amRNSNet Asset Value(s)
4th Apr 20241:26 pmRNSNet Asset Value(s)
3rd Apr 20244:35 pmRNSResult of Meeting & Special Dividend Announcement
3rd Apr 20243:37 pmRNSHolding(s) in Company
3rd Apr 202411:52 amRNSNet Asset Value(s)
2nd Apr 20241:07 pmRNSNet Asset Value(s)
2nd Apr 202411:15 amRNSCancellation of Treasury Shares
28th Mar 202412:31 pmRNSNet Asset Value(s)
28th Mar 20249:18 amRNSHolding(s) in Company
27th Mar 202411:59 amRNSNet Asset Value(s)
26th Mar 202411:48 amRNSNet Asset Value(s)
25th Mar 202412:14 pmRNSNet Asset Value(s)
22nd Mar 20244:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.